Do you or someone you know have urethral stricture disease?

Participants may be eligible to participate in a study if:

• they’re male
• they’ve been diagnosed with a stricture
• they’ve had prior treatments
• they’ve experienced significant symptoms of stricture such as frequency of urination, urgency and slow flow of urine

What is the purpose of this research study?

This study is designed to assess the safety and efficacy of a drug-coated balloon (DCB) in the treatment of anterior urethral strictures.

What is a drug-coated balloon and how is it used?

A DC A DCB is a small cylindrical balloon, coated in medication that is engineered to slow or stop the development of scar tissue that causes urethral strictures. The investigational treatment takes about fifteen minutes and is done on an outpatient basis. DCBs have been successfully used in cardiovascular procedures for several years and have proven to effectively reduce the need for re-treatment.

Subjects may receive a travel stipend.